Skip to main content
SpringerLink
Log in

Control and Perspectives for Elimination of Taenia solium Taeniasis/Cysticercosis

  • Chapter
  • First Online:
Cysticercosis of the Human Nervous System

  • 1259 Accesses

Abstract

As previously discussed in this book, Taenia solium is endemic in vast parts of the world, in particular, in regions where pigs are raised as domestic animals in rural areas. The resulting disease, neurocysticercosis, is also present in non-endemic regions because of travel and immigration. Taeniasis/cysticercosis exerts a significant economic impact worldwide, most of which is associated with human neurocysticercosis, although there are other associated costs related to porcine cysticercosis (Bhattarai et al. 2012; Praet et al. 2009; Torgerson and Macpherson 2011). The substantial contribution of neurocysticercosis to the burden of neurological disease in Latin America has been estimated as between 23,512 and 39,186 symptomatic neurocysticercosis cases in Peru, and approximately, 400,000 in Latin America (Bern et al. 1999). Even in non-endemic regions, immigrants with neurocysticercosis may become a significant economic burden for health systems. General costs related to neurocysticercosis in California, USA, have been estimated to be $17 million, with hospital costs above $5 million (Croker et al. 2012).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alexander A, John KR, Jayaraman T et al (2011) Economic implications of three strategies for the control of taeniasis. Trop Med Int Health 16(11):1410–1416

    Article  PubMed  Google Scholar 

  • Allan JC, Avila G, Garcia Noval J, Flisser A, Craig PS (1990) Immunodiagnosis of taeniasis by coproantigen detection. Parasitology 101(Pt 3):473–477

    Article  PubMed  Google Scholar 

  • Allan JC, Velasquez-Tohom M, Fletes C, Torres-Alvarez R, Lopez-Virula G, Yurrita P, Soto de Alfaro H, Rivera A, Garcia-Noval J (1997) Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans R Soc Trop Med Hyg 91:595–598

    Article  PubMed  Google Scholar 

  • Assana E, Kyngdon CT, Gauci CG et al (2010) Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 40(5):515–519

    Article  PubMed  CAS  Google Scholar 

  • Bern C, García HH, Evans C et al (1999) Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29(5):1203–1209

    Article  PubMed  CAS  Google Scholar 

  • Bhattarai R, Budke CM, Carabin H et al (2012) Estimating the non-monetary burden of neurocysticercosis in Mexico. PLoS Med 6(2):1–10

    Google Scholar 

  • Bustos JA, Rodriguez S, Jimenez JA et al (2012) Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol 19(4):570–573

    Article  PubMed  CAS  Google Scholar 

  • Croker C, Redelings M, Reporter R, Sorvillo F, Mascola L, Wilkins P (2012) The impact of neurocysticercosis in California: a review of hospitalized cases. PLoS Med 6(1):1–6

    Google Scholar 

  • Cruz M, Davis A, Dixon H, Pawlowski ZS, Proano J (1989) Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. Bull World Health Organ 67(4):401–407

    PubMed  CAS  Google Scholar 

  • Cysticercosis Working Group in Peru (1993) The marketing of cysticercotic pigs in the Sierra of Peru. Bull World Health Organ 71(2):223–228

    Google Scholar 

  • Del Brutto OH, Santibanez R, Idrovo L et al (2005) Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46(4):583–587

    Article  PubMed  Google Scholar 

  • Díaz Camacho SP, Candii Ruiz A, Suate Peraza V, Vezueta Ramos ML, Felix Medina M, Lozano R, Willms K (1991) Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico. Am J Trop Med Hyg 45:522–531

    Article  PubMed  Google Scholar 

  • Engels D, Meslin FJ, Prilipko LL, Saraceno B, Savioli L (2003) Neurocysticercosis: reducing the burden of disease is an even more attainable goal. BMJ 326:511–512

    Article  Google Scholar 

  • Flisser A, Gonzalez D, Plancarte A et al (1990a) Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies. Parasitol Res 76(7):640–642

    Article  PubMed  CAS  Google Scholar 

  • Flisser A, Gonzalez D, Shkurovich M et al (1990b) Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies. Parasitol Res 76(3):263–269

    Article  PubMed  CAS  Google Scholar 

  • Flisser A, Madrazo I, Plancarte A et al (1993) Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet 342(8873):748

    Article  PubMed  CAS  Google Scholar 

  • Flisser A, Gauci CG, Zoli A et al (2004) Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 72(9):5292–5297

    Article  PubMed  CAS  Google Scholar 

  • Flisser A, Avila G, Maravilla P et al (2010) Taenia solium: current understanding of laboratory animal models of taeniosis. Parasitology 137(3):347–357

    Article  PubMed  CAS  Google Scholar 

  • García HH, Gilman RH, Gonzalez AE et al (2003) Hyperendemic human and porcine Taenia solium infection in Peru. Am J Trop Med Hyg 68(3):268–275

    PubMed  Google Scholar 

  • García HH, Gonzalez AE, Gilman RH et al (2006) Combined human and porcine mass chemotherapy for the control of T. solium. Am J Trop Med Hyg 74(5):850–855

    PubMed  Google Scholar 

  • García HH, Gonzalez AE, Del Brutto OH et al (2007a) Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci 262(1–2):153–157

    Article  PubMed  Google Scholar 

  • García HH, Gonzalez I, Mija L (2007b) Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med 356(12):1277–1278

    Article  PubMed  Google Scholar 

  • Gemmell M, Matyas Z, Pawlowsky Z, Soulsby EJL (1983) Guidelines for surveillance and control of taeniasis/cysticercosis, vol 83.49. World Health Organization, Geneva

    Google Scholar 

  • Gonzalez AE (1997) Evaluation of a control programme for Taenia solium targeting human and porcine health. PhD thesis, University of Reading

    Google Scholar 

  • Gonzalez AE, Cama V, Gilman RH et al (1990) Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg 43(2):194–199

    PubMed  CAS  Google Scholar 

  • Gonzalez AE, Gilman R, García HH et al (1994) Use of sentinel pigs to monitor environmental Taenia solium contamination. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg 51(6):847–850

    PubMed  CAS  Google Scholar 

  • Gonzalez AE, García HH, Gilman RH et al (1995) Treatment of porcine cysticercosis with albendazole. Am J Trop Med Hyg 53(5):571–574

    PubMed  CAS  Google Scholar 

  • Gonzalez AE, Gauci CG, Barber D et al (2005) Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg 72(6):837–839

    PubMed  Google Scholar 

  • Guo YJ, Sun SH, Zhang Y et al (2004) Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine. Vaccine 22(29–30):3841–3847

    Article  PubMed  CAS  Google Scholar 

  • Guo A, Jin Z, Zheng Y et al (2007) Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination. Vaccine 25(1):170–175

    Article  PubMed  CAS  Google Scholar 

  • Huerta M, de Aluja AS, Fragoso G et al (2002) Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 20(1–2):262–266

    Google Scholar 

  • International Task Force for Disease Eradication (1993) Recommendations of the International Task Force for Disease Eradication. MMWR Morb Mortal Wkly Rep 42(RR-16):1–38

    Google Scholar 

  • Johnson RB (1986) Potential hazard of mass praziquantel use. Am J Med 80(6):A88

    Article  PubMed  CAS  Google Scholar 

  • Keilbach NM, de Aluja AS, Sarti-Gutierrez E (1989) A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. Acta Leiden 57(2):181–189

    PubMed  CAS  Google Scholar 

  • Leon-Cabrera S, Cruz-Rivera M, Mendlovic F et al (2009) Standardization of an experimental model of human taeniosis for oral vaccination. Methods 49(4):346–350

    Article  PubMed  CAS  Google Scholar 

  • Mahanty S, García HH (2010) Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol 91(2):172–184

    Article  PubMed  CAS  Google Scholar 

  • Medina MT, Aguilar-Estrada RL, Alvarez A et al (2011) Reduction in rate of epilepsy from neurocysticercosis by community interventions: the Salama, Honduras study. Epilepsia 52(6):1177–1185

    Article  PubMed  Google Scholar 

  • Molinari JL, Soto R, Tato P et al (1993) Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. Am J Trop Med Hyg 49(4):502–512

    PubMed  CAS  Google Scholar 

  • Montano SM, Villaran MV, Ylquimiche L et al (2005) Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 65(2):229–233

    Article  PubMed  CAS  Google Scholar 

  • Nascimento E, Costa JO, Guimaraes MP, Tavares CA (1995) Effective immune protection of pigs against cysticercosis. Vet Immunol Immunopathol 45(1–2):127–137

    Article  PubMed  CAS  Google Scholar 

  • Ndimubanzi PC, Carabin H, Budke CM et al (2010) A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4(11):e870

    Article  PubMed  Google Scholar 

  • Newton CR, García HH (2012) Epilepsy in poor regions of the world. Lancet 380(9848):1193–1201

    Article  PubMed  Google Scholar 

  • Ngowi HA, Carabin H, Kassuku AA, Mlozi MR, Mlangwa JE, Willingham AL 3rd (2008) A health-education intervention trial to reduce porcine cysticercosis in Mbulu District, Tanzania. Prev Vet Med 85(1–2):52–67

    Article  PubMed  CAS  Google Scholar 

  • Ngowi HA, Kassuku AA, Carabin H et al (2010) Spatial clustering of porcine cysticercosis in Mbulu district, northern Tanzania. PLoS Negl Trop Dis 4(4):e652

    Article  PubMed  Google Scholar 

  • O’Neal SE, Moyano LM, Ayvar V et al (2012) Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs. PLoS Negl Trop Dis 6(12):e1953

    Article  PubMed  Google Scholar 

  • Onah DN, Chiejina SN (1995) Taenia solium cysticercosis and human taeniasis in the Nsukka area of Enugu State, Nigeria. Ann Trop Med Parasitol 89(4):399–407

    PubMed  CAS  Google Scholar 

  • Pawlowski Z, Allan J, Sarti E (2005) Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. Int J Parasitol 35(11–12):1221–1232

    Article  PubMed  Google Scholar 

  • Peniche-Cardena A, Dominguez-Alpizar JL, Sima-Alvarez R et al (2002) Chemotherapy of porcine cysticercosis with albendazole sulphoxide. Vet Parasitol 108(1):63–73

    Article  PubMed  CAS  Google Scholar 

  • Plancarte A, Flisser A, Gauci CG, Lightowlers MW (1999) Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens. Int J Parasitol 29(4):643–647

    Article  PubMed  CAS  Google Scholar 

  • Pondja A, Neves L, Mlangwa J et al (2012) Use of oxfendazole to control porcine cysticercosis in a high-endemic area of Mozambique. PLoS Med 6(5):1–5

    Google Scholar 

  • Praet N, Speybroeck N, Manzanedo R et al (2009) The disease burden of Taenia solium cysticercosis in Cameroon. PLoS Negl Trop Dis 3(3):e406

    Article  PubMed  Google Scholar 

  • Ramos-Zuniga R, Perez-Gomez R, Jauregui-Huerta F et al (2013) Incidental consequences of anthelmintic treatment in the central nervous system. World Neurosurg 79(1):149–153

    Article  PubMed  Google Scholar 

  • Sarti E, Flisser A, Schantz PM et al (1997) Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg 56(2):127–132

    PubMed  CAS  Google Scholar 

  • Sarti E, Schantz PM, Avila G, Ambrosio J, Medina-Santillan R, Flisser A (2000) Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study. Trans R Soc Trop Med Hyg 94(1):85–89

    Article  PubMed  CAS  Google Scholar 

  • Sotelo J, Rosas N, Palencia G (1986) Freezing of infested pork muscle kills cysticerci. JAMA 256(7):893–894

    Article  PubMed  CAS  Google Scholar 

  • Tellez-Giron E, Ramos MC, Montante M (1981) Effect of flubendazole on cysticercus cellulosae in pigs. Am J Trop Med Hyg 30(1):135–138

    PubMed  CAS  Google Scholar 

  • Torgerson PR, Macpherson CN (2011) The socioeconomic burden of parasitic zoonoses: global trends. Vet Parasitol 182(1):79–95

    Article  PubMed  Google Scholar 

  • Torres JR, Noya O, de Noya BA, Mondolfi A (1988) Seizures and praziquantel. A case report. Rev Inst Med Trop Sao Paulo 30(6):433–436

    Article  PubMed  CAS  Google Scholar 

  • Verastegui M, Gilman RH, Gonzalez AE et al (2002) Taenia solium oncosphere antigen induce immunity in pigs against experimental cysticercosis. Vet Parasitol 108:49–62

    Article  PubMed  CAS  Google Scholar 

  • Verster A, Du Plessis TA, Van Den Heever LW (1976) The effect of gamma radiation on the cysticerci of Taenia solium. Onderstepoort J Vet Res 43(1):23–26

    PubMed  CAS  Google Scholar 

  • Wang QM, Sun SH, Hu ZL, Wu D, Wang ZC (2003) Immune response and protection elicited by DNA immunisation against Taenia cysticercosis. Vaccine 21(15):1672–1680

    Article  PubMed  CAS  Google Scholar 

  • Wu W, Qian X, Huang Y, Hong Q (2012) A review of the control of clonorchiasis sinensis and Taenia solium taeniasis/cysticercosis in China. Parasitol Res 111(5):1879–1884. doi: 10.1007/s00436-012-3152-y

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Universidad Espíritu Santo, Santo, Ecuador

    Oscar H. Del Brutto

  2. Department of Neurological Sciences, Hospital-Clinica Kennedy, Guayaquil, Ecuador

    Oscar H. Del Brutto

  3. Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru

    Héctor H. García

  4. School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru

    Héctor H. García

Authors
  1. Oscar H. Del Brutto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Héctor H. García
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Del Brutto, O.H., García, H.H. (2014). Control and Perspectives for Elimination of Taenia solium Taeniasis/Cysticercosis. In: Cysticercosis of the Human Nervous System. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39022-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39022-7_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39021-0

  • Online ISBN: 978-3-642-39022-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation